The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) along with the University of Delaware are pleased to announce $3M in Congressionally-directed funding from the National Institute of Standards and Technology (NIST) for new equipment which will support the advancement of biopharmaceutical manufacturing processes and...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities through the Institute’s Project Call 5.2 for 14 new projects in technology and workforce development that will help to address key opportunities for innovation in the biopharmaceutical industry...

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded nearly $54 million in grants for 13 high-impact projects for research, development and testbeds for pandemic response. The funding, which was provided by the American Rescue Act, will support projects at eight manufacturing innovation institutes in...

Today, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the United States funded through the American Rescue Plan (ARP).

NIIMBL identified projects that will help the nation prevent, prepare for, and respond to coronavirus public health...

This summer, a group of talented students received a jump start on a career in the biopharmaceutical industry during the NIIMBL eXperience.

Building on the success of previous years, NIIMBL held its third eXperience from June 14 – 25, 2021. This program gives African American/Black, Latinx and Native American college freshmen and sophomores an...